1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296

Glenmark Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Incorporated in 1977, Glenmark Pharmaceuticals is engaged in the business of development, manufacturing and marketing of pharmaceutical products. The company products in key therapeutic areas includes dermatology, respiratory, oncology, cardiology, d...

Read More
2077.00 -22.50 (-1.07%)
62.84% Gain from 52W Low
588.4K
NSE+BSE Volume

NSE 16 Sep, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert
Dividend
Glenmark Pharmaceuticals Ltd. last dividend of ₹2.50 per share was given on 15 Sep 2025 See details
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
70.0 / 100
Valuation Score
Mid Valuation
33.5 / 100
Momentum Score
Technically Moderately Bullish
69.3 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
2,249
1Yr Price target upside is 8%
12 analysts

18

S

8

W

7

O

3

T

SWOT Analysis

Glenmark Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
Is Glenmark Pharmaceuticals Ltd. worth buying?
571 Votes:
Buy 79.33%
Sell 13.66%
Hold 7.01%
BUY
SELL
HOLD